Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Change in Account Payables (2016 - 2025)

Veracyte's Change in Account Payables history spans 14 years, with the latest figure at -$492000.0 for Q4 2025.

  • For Q4 2025, Change in Account Payables rose 63.69% year-over-year to -$492000.0; the TTM value through Dec 2025 reached -$1.0 million, up 75.87%, while the annual FY2025 figure was -$1.0 million, 75.87% up from the prior year.
  • Change in Account Payables for Q4 2025 was -$492000.0 at Veracyte, up from -$3.7 million in the prior quarter.
  • Across five years, Change in Account Payables topped out at $7.1 million in Q1 2025 and bottomed at -$4.0 million in Q2 2025.
  • The 5-year median for Change in Account Payables is -$366000.0 (2022), against an average of -$8550.0.
  • The largest YoY upside for Change in Account Payables was 561.14% in 2025 against a maximum downside of 2373.46% in 2025.
  • A 5-year view of Change in Account Payables shows it stood at $1.3 million in 2021, then plummeted by 62.82% to $477000.0 in 2022, then plummeted by 166.88% to -$319000.0 in 2023, then plummeted by 324.76% to -$1.4 million in 2024, then soared by 63.69% to -$492000.0 in 2025.
  • Per Business Quant, the three most recent readings for VCYT's Change in Account Payables are -$492000.0 (Q4 2025), -$3.7 million (Q3 2025), and -$4.0 million (Q2 2025).